FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Avanse Financial Services IPO and Suraksha Diagnostic IPO.
Avanse Financial Services IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Suraksha Diagnostic IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Avanse Financial Services IPO | Suraksha Diagnostic IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Avendus Capital Pvt Ltd J.P. Morgan India Private Limited Nomura Financial Advisory And Securities (India) Pvt Ltd Nuvama Wealth Management Limited SBI Capital Markets Limited |
ICICI Securities Limited Nuvama Wealth Management Limited SBI Capital Markets Limited |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | |
Anchor Investor | ||
IPO Allotment URL |
The total issue size of Avanse Financial Services IPO is up to ₹3,500.00 Cr whereas the issue size of the Suraksha Diagnostic IPO is up to ₹846.25 Cr. The final issue price of Avanse Financial Services IPO is and of Suraksha Diagnostic IPO is .
Avanse Financial Services IPO | Suraksha Diagnostic IPO | |
---|---|---|
Face Value | ₹5 per share | ₹2 per share |
Issue Price (Lower) | ₹420.00 per share | |
Issue Price (Upper) | ₹441.00 per share | |
Issue Price (Final) | ||
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 34 shares | |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹1,000.00 Cr | |
OFS Issue Size | 1,91,89,330 shares | |
OFS Issue Size (Amount) | up to ₹2,500.00 Cr | up to ₹846.25 Cr |
Issue Size Total | 1,91,89,330 shares | |
Issue Size Total (Amount) | up to ₹3,500.00 Cr | up to ₹846.25 Cr |
Avanse Financial Services IPO opens on , while Suraksha Diagnostic IPO opens on Nov 29, 2024. The closing date of Avanse Financial Services IPO and Suraksha Diagnostic IPO is , and Dec 03, 2024, respectively.
Avanse Financial Services IPO | Suraksha Diagnostic IPO | |
---|---|---|
Anchor Bid Date | Nov 28, 2024 | |
Issue Open | Nov 29, 2024 | |
Issue Close | Dec 03, 2024 | |
Basis Of Allotment (Tentative) | Dec 04, 2024 | |
Initiation of Refunds (Tentative) | Dec 05, 2024 | |
Credit of Share (Tentative) | Dec 05, 2024 | |
Listing date (Tentative) | Dec 06, 2024 | |
Anchor Lockin End date 1 | Jan 03, 2025 | |
Anchor Lockin End date 2 | Mar 04, 2025 |
Avanse Financial Services IPO P/E ratio is , as compared to Suraksha Diagnostic IPO P/E ratio of 99.31.
Avanse Financial Services IPO | Suraksha Diagnostic IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Avanse Financial Services Limited Financial Information (Restated Consolidated)Avanse Financial Services Limited's revenue increased by 75% and profit after tax (PAT) rose by 117% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Suraksha Diagnostic Limited Financial Information (Restated Consolidated)Suraksha Diagnostic Limited's revenue increased by 14.75% and profit after tax (PAT) rose by 281.32% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 58.38% | 61.07% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 99.31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 14.09%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 21.46%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹4.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 14.09%% |
In the Avanse Financial Services IPO retail investors (RII) are offered while in Suraksha Diagnostic IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Avanse Financial Services IPO and in Suraksha Diagnostic IPO.
Avanse Financial Services IPO | Suraksha Diagnostic IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | ||
NII | ||
RII | ||
Employee | ||
Others | ||
Total |
Avanse Financial Services IPO subscribed in total, whereas Suraksha Diagnostic IPO subscribed .
Avanse Financial Services IPO | Suraksha Diagnostic IPO | |
---|---|---|
QIB (times) | ||
NII (times) | ||
Big NII (times) | ||
Small NII (times) | ||
RII (times) | ||
Employee (times) | ||
Other (times) | ||
Total (times) |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|